发明名称 |
USING TYPE III PEGYLATED INTERFERONS FOR TREATING HEPATITIS C |
摘要 |
FIELD: medicine.SUBSTANCE: group of inventions refers to medicine, namely to infectious diseases and may be used for treating and preventing hepatitis C in an individual received no drug therapy while being infected or at a risk of infection. That is ensured by subcutaneous introduction of mPEG-propionaldehyde pegylated polypeptide 1.5-5.0 mcg/kg having molecular weight approximately 20 kDa. The polypeptide contains the amino acid residues 1-176 SEQ ID NO: 106. and is pegylated type III interferon.EFFECT: group of inventions provides treating hepatitis C in the above group of patients and reducing the toxic effects of the drugs administered.11 cl, 113 dwg, 18 tbl, 1 ex |
申请公布号 |
RU2496514(C2) |
申请公布日期 |
2013.10.27 |
申请号 |
RU20100154092 |
申请日期 |
2009.06.05 |
申请人 |
ZAJMODZHINETIKS, INK.;BRISTOL'-MEJERZ KVIBB KOMPANI |
发明人 |
KHOSMAN DIANA F.;DODDS MAJKL G. |
分类号 |
A61K38/21;A61K38/20;A61P31/20 |
主分类号 |
A61K38/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|